NO991227L - PTX-sensitive G-proteiner, deres fremstilling og bruk - Google Patents

PTX-sensitive G-proteiner, deres fremstilling og bruk

Info

Publication number
NO991227L
NO991227L NO991227A NO991227A NO991227L NO 991227 L NO991227 L NO 991227L NO 991227 A NO991227 A NO 991227A NO 991227 A NO991227 A NO 991227A NO 991227 L NO991227 L NO 991227L
Authority
NO
Norway
Prior art keywords
ptx
proteins
sensitive
preparation
subunit
Prior art date
Application number
NO991227A
Other languages
English (en)
Other versions
NO991227D0 (no
Inventor
Winfried Siffert
Original Assignee
Winfried Siffert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Winfried Siffert filed Critical Winfried Siffert
Publication of NO991227L publication Critical patent/NO991227L/no
Publication of NO991227D0 publication Critical patent/NO991227D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)

Abstract

Beta-3-subenhet for et humant G-protein, bestående hovedsakelig av 6 WD-repeterende struktur.
NO991227A 1996-09-13 1999-03-12 PTX-sensitive G-proteiner, deres fremstilling og bruk NO991227D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19637518A DE19637518A1 (de) 1996-09-13 1996-09-13 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung
PCT/EP1997/004709 WO1998011212A1 (de) 1996-09-13 1997-08-29 Ptx-sensitive g-proteine, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
NO991227L true NO991227L (no) 1999-03-12
NO991227D0 NO991227D0 (no) 1999-03-12

Family

ID=7805651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991227A NO991227D0 (no) 1996-09-13 1999-03-12 PTX-sensitive G-proteiner, deres fremstilling og bruk

Country Status (22)

Country Link
US (1) US6251853B1 (no)
EP (1) EP0931145A1 (no)
JP (1) JP2001501811A (no)
KR (1) KR20000036058A (no)
CN (1) CN1230222A (no)
AU (1) AU4619297A (no)
BG (1) BG103238A (no)
BR (1) BR9711475A (no)
CA (1) CA2265467A1 (no)
CZ (1) CZ73499A3 (no)
DE (1) DE19637518A1 (no)
EA (1) EA199900253A1 (no)
EE (1) EE9900092A (no)
HU (1) HUP9904110A3 (no)
IL (1) IL128746A0 (no)
IS (1) IS4987A (no)
NO (1) NO991227D0 (no)
PL (1) PL332417A1 (no)
SK (1) SK34099A3 (no)
TR (1) TR199900500T2 (no)
WO (1) WO1998011212A1 (no)
ZA (1) ZA978220B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen
WO1999058669A1 (en) * 1998-05-11 1999-11-18 Axys Pharmaceuticals, Inc. Rhoh genes and their uses
DK1112362T3 (da) * 1998-09-10 2006-06-19 Eurofins Medigenomix Gmbh Genforandring i genet for G$g(b)3-underenheden i det menneskelige G-protein
FR2803525B1 (fr) * 2000-01-06 2002-05-03 Sod Conseils Rech Applic Inhibiteur de la transduction des signaux des proteines g heterotrimeriques associe a un agent anti-hypertenseur dans le traitement de l'hypertension arterielle
CA2399141A1 (en) * 2000-02-03 2001-08-09 Snip Biotech Gmbh & Co. Kg Use of a mutation in the gene for the .beta.3-subunit of human g-protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587561A (en) 1995-07-28 1996-12-24 Budayr; Mahdi Stethoscope shield
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen

Also Published As

Publication number Publication date
IS4987A (is) 1999-02-26
EA199900253A1 (ru) 1999-10-28
KR20000036058A (ko) 2000-06-26
EE9900092A (et) 1999-10-15
SK34099A3 (en) 2000-05-16
WO1998011212A1 (de) 1998-03-19
CA2265467A1 (en) 1998-03-19
DE19637518A1 (de) 1998-04-09
BR9711475A (pt) 1999-08-24
HUP9904110A3 (en) 2001-09-28
BG103238A (bg) 2000-06-30
CN1230222A (zh) 1999-09-29
JP2001501811A (ja) 2001-02-13
IL128746A0 (en) 2000-01-31
HUP9904110A2 (en) 2000-07-28
TR199900500T2 (xx) 1999-06-21
US6251853B1 (en) 2001-06-26
ZA978220B (en) 1999-03-12
EP0931145A1 (de) 1999-07-28
NO991227D0 (no) 1999-03-12
AU4619297A (en) 1998-04-02
PL332417A1 (en) 1999-09-13
CZ73499A3 (cs) 1999-07-14

Similar Documents

Publication Publication Date Title
DK614289A (da) Konjugater af et membranprotein og et peptid, deres fremstilling og anvendelse
DK0871656T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
NO961160L (no) Cykliske forbindelser, deres fremstilling og anvendelse
DK374389A (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO900469D0 (no) Piperidinforbindelser, deres fremstilling og anvendelse.
EP0832125A4 (en) Human g-protein receptor hgber32
DK1009750T3 (da) Nye (alfa-aminophosphino)peptid derivater, fremgangsmåde til deres fremstilling og deres terapeutiske anvendelse
DK388989D0 (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
DK435289A (da) Piperazindioner, deres fremstilling og anvendelse
NO962477L (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
DK698188D0 (da) Peptider, deres fremstilling og anvendelse
DK199989D0 (da) Angucyclinoner fra streptomyceter, deres fremstilling og anvendelse
NO973230D0 (no) Nye peptider, deres fremstilling og anvendelse
DK51789A (da) Aminosyreamider, deres fremstilling og anvendelse
DK225089A (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
NO991227D0 (no) PTX-sensitive G-proteiner, deres fremstilling og bruk
DK162087D0 (da) Piperidinforbindelser, deres fremstilling og anvendelse
NO972822D0 (no) Fluoralkylglycosiduronsyrer og tilsvarende 6(3)-lactoner, deres fremstilling og anvendelse
DK185489D0 (da) Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
DK592389D0 (da) Penemderivater, deres fremstilling og anvendelse
DK202089A (da) Angucyclinoner fra streptomyceter, deres fremstilling og anvendelse
DK224187A (da) Cycliske peptider, deres fremstilling og anvendelse
ATE366261T1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application